In his new role, he will oversee customer strategy and relationships across both biotech and pharmaceutical sectors worldwide. He will also oversee clinical development capabilities from Phase I to IV.
In his new role, he will oversee customer strategy and relationships across both biotech and pharmaceutical sectors worldwide. He will also oversee clinical development capabilities from Phase I to IV.